Results

1–3 of 3 results for anti-vascular endothelial growth factor therapy

Conversion Rates from Nonexudative to Exudative Age-Related Macular Degeneration: An AAO IRIS® Registry Analysis
Dan A Gong, MD
Annual Meeting Talks
2022
Cognitive Testing in Patients Receiving Intravitreal Anti-Vascular Endothelial Growth Factor Therapy for Wet Age-Related Macular Degeneration
Subhransu K. Ray, MD, PhD
Annual Meeting Talks
2020
Visual Acuity Outcomes of Intravitreal Anti-Vascular Endothelial Growth Factor Therapy for Retinal Vein Occlusion in Routine Clinical Practice
Yasha S Modi, MD
On Demand Cases, Courses, and Papers
2019